Therapeutics: Dendritic cell-specific ICAM-3 grabbing nonintegrin (DC-SIGN; CD209)

Mouse studies suggest activating DC-SIGN could help treat pulmonary fibrosis and other fibrotic diseases. In a mouse model of acute lung inflammation, a small molecule activator of DC-SIGN decreased n...